Press Release 4DMT Reports Second Quarter 2026 Financial Results, Operational Highlights and Expected Upcoming Milestones Aug 13
Press Release 4DMT Announces Positive 2-Year Data from PRISM Phase 2b Clinical Trial in a Broad Wet AMD Population Jul 18